Page last updated: 2024-09-03

1,9-dimethylmethylene blue and Hemolysis

1,9-dimethylmethylene blue has been researched along with Hemolysis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besselink, GA; Blokker, DE; Brand, A; De Korte, D; Korsten, HG; Lagerberg, JW; Van Engelenburg, FA; Verhoeven, AJ1
Cincotta, L; Mallory, DA; Robinette, D; Skripchenko, A; Wagner, SJ1

Other Studies

2 other study(ies) available for 1,9-dimethylmethylene blue and Hemolysis

ArticleYear
The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
    Transfusion, 2002, Volume: 42, Issue:6

    Topics: Anion Exchange Protein 1, Erythrocyte; Diarrhea Viruses, Bovine Viral; Dipyridamole; Encephalomyocarditis virus; Erythrocyte Membrane; Erythrocytes; Free Radical Scavengers; Hemolysis; Herpesvirus 1, Suid; HIV-1; Humans; Ligands; Methylene Blue; Oxidative Stress; Parvovirus, Canine; Photochemistry; Photochemotherapy; Radiation-Protective Agents; Radiation-Sensitizing Agents; Vesicular stomatitis Indiana virus; Viruses

2002
Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue.
    Transfusion, 1998, Volume: 38, Issue:8

    Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Blood Preservation; Diarrhea Viruses, Bovine Viral; Encephalomyocarditis virus; Erythrocytes; Hemolysis; Herpesvirus 1, Suid; Humans; Light; Methylene Blue; Osmotic Fragility; Photosensitizing Agents; Potassium; Vesicular stomatitis Indiana virus; Virus Activation

1998